1-苯基-3-甲基-4-苯甲酰吡唑啉酮-5萃取镓的研究

首次报道了1-苯基-3-甲基-4-苯甲酰吡唑啉酮-5(HPMBP)萃取镓的热力学和动力学, 指出在体系中形成Ga(PMBP)3(H2O)2萃合物, 配体PMBP既有一次溶剂化作用, 又有二次溶剂化作用, 并得到红外光谱和核磁共振谱的证实。镓的萃取过程为水相化学反应控制, 决速步骤为一次溶剂化过程: Ga^3^++HPMBP→Ga(PMBP)^2^++H^+。添加剂三辛基氧化膦(TOPO)不影响HPMBP萃取镓的分配比, 但降低了HPMBP萃取镓的正向速率, 表明动力学抑萃作用与热力学抑萃作用无对应关系。     

铽与1-苯基-3-甲基-4-酰代吡唑啉-5-酮的三元配合物的合成、表征与荧光性能

合成了铽与1-苯基-3-甲基-4-异丁酰基吡唑啉-5-酮(HPMIBP)、1-苯基-3-甲基-4-苯甲酰基吡唑啉-5-酮(HPMBP)的四个三元配合物Tb(PMIBP)3.2H2O(A1), Tb(PMIBP)3.bpy(A2), Tb(PMBP)3.2H2O(B1)和Tb(PMBP)3.bpy(B2)(bpy=2, 2'-联吡啶)。用元素分析确定了它们的组成, 并用紫外-可见光谱、红外光谱、差热-热重谱对其进行了表征。研究了它们在固态和溶液中的荧光光谱, 并用频域法测定了它们在溶液中的荧光寿命, 结果表明A1和A2的荧光强度比相应的B1和B2强三个数量级, A2与A1或B2与B1相比, 荧光强度也有一定程度的增强,并且不同溶剂对其荧光强度和荧光寿命都有较大的影响。     

铽与1-苯基-3-甲基-4-酰代吡唑啉-5-酮的三元配合物的合成、表征与荧光性能

合成了铽与1-苯基-3-甲基-4-异丁酰基吡唑啉-5-酮(HPMIBP)、1-苯基-3-甲基-4-苯甲酰基吡唑啉-5-酮(HPMBP)的四个三元配合物Tb(PMIBP)3.2H2O(A1), Tb(PMIBP)3.bpy(A2), Tb(PMBP)3.2H2O(B1)和Tb(PMBP)3.bpy(B2)(bpy=2, 2'-联吡啶)。用元素分析确定了它们的组成, 并用紫外-可见光谱、红外光谱、差热-热重谱对其进行了表征。研究了它们在固态和溶液中的荧光光谱, 并用频域法测定了它们在溶液中的荧光寿命, 结果表明A1和A2的荧光强度比相应的B1和B2强三个数量级, A2与A1或B2与B1相比, 荧光强度也有一定程度的增强,并且不同溶剂对其荧光强度和荧光寿命都有较大的影响。     

含吡唑啉酮酰肼类衍生物的合成与结构

报道了PMBP-NTH(NTH为烟酰肼)与PMBP-PAH(PAH为对甲氧基苯甲酰肼)的合成、表征和晶体结构分析,PMBP-NTH晶体属三斜晶系,具有P1空间群,a=0.9024(2)nm,b=1.0953(2)nm,c=1.1635(2)nm,α67.070(10)°,β=68.220(10)°,γ=84.770(10)°,V=0.9816(3)nm^3,Z=2,Dc=1.345g/cm^3,μ=0.090mm^-1,F(000)=416,R=0.0363,ωR=0.0870.PMBP-PAH属单斜晶系,具有P21/c空间群,a=1.2715(4)nm,b=0.91710(10)nm,c=1.8979(3)nm,β=106.890(10)°,V=2.1177(8)nm^3,Z=4,Dc=1.338g/cm^3,μ=0.090mm^-1,F(000)=896,R=0.0414,ωR=0.0972.这两个化合物在分子内都形成了大的共轭体系,由于分子间氢键力的作用,又使它们在晶体中以二聚体形式存在.     

α-羰基一硫代半缩醛与脂肪族脲反应合成2, 4-咪唑啉二酮衍生物

利用α-羰基一硫代半缩醛与脂肪基取代脲反应合成了六个新的咪唑啉二酮类衍生物。并用IR,NMR,MS和元素分析进行测定,最后用X四圆衍射仪确定了它们的结构。     

双缩二氨基硫脲类化合物的合成与结构

合成了1，5-二（4-甲氧基苯甲醛）双缩二氨基硫脲（1），1，5-二（对二甲 基氨基苯甲醛）双缩二氨基硫脲（2），1，5-二（2-呋喃甲醛）双缩二氨基硫脲（ 3）三个化合物，并通过元素分析、红外光谱、核磁共振、质谱进行了结构表征。 首次报道了双缩二氨基硫脲类化合物的^13C NMR数据，并发现在溶液中由于构象异 构体或二聚体的存在，该类化合物的部分^13C NMR谱峰出现矮而宽、不易检测的特 征。配体1形成的晶体为单斜晶系，具有P21/c空间群，a=1.4363(3)nm，b=1.2622 (2)nm，c=1.0970(2)nm，β=101.730（10）°，V=1.9472（6）nm^3，Z=4，Dc=1. 318g/cm^3，μ=0.193mm^-1，F(000)=816，R1=0.0560，ωR2=0.1496。由于分子间 弱氢键力的作用，在晶体中以二聚体的形式存在。     

一种新的含吡唑啉酮氨基硫脲化合物的晶体结构及其光致变色性质

A new photochromic organic compound of thiosemicarbazone, 4-（p-bromo-α-methylaminothiocarbonyl hydrazonobenzal）-2,5-dihydro-3-mcthyl-5-oxo-1-phcnyl pyrazolc, was synthesized and characterized by elemental analyses, IR, ^1H NMR spectra, and X-ray single-crystal diffraction analysis. The compound exhibited an interesting photochromism in the solid state when irradiated by ultraviolet light at 365 nm. The photochromic kinetics was studied by the time-dependent powder UV-Vis reflectance spectra. The intcrmolecular and intramolecular hydrogcn-bonding interactions may be responsible for the photochromic phenomenon.     

双吡唑啉酮类螯合剂1,6-双[4'-(1'-苯基-3'-甲基-5'-氧代)吡唑啉基]-1.6-已二酮与铀、钍固体配合物合成及表征

本文报道了1,6-双[4'-(1'-苯基-3'-甲基-5'-氧代)吡唑啉基]-1,6-已酮与铀、钍固体配合物的组成。从红外光谱、质子核磁共振谱、差热曲线及微分热重曲线的数据, 得到了其配位状态方面信息。     

双吡唑啉酮类螯合剂1,6-双[4'-(1'-苯基-3'-甲基-5'-氧代)吡唑啉基]-1.6-已二酮与铀、钍固体配合物合成及表征

本文报道了1,6-双[4'-(1'-苯基-3'-甲基-5'-氧代)吡唑啉基]-1,6-已酮与铀、钍固体配合物的组成。从红外光谱、质子核磁共振谱、差热曲线及微分热重曲线的数据, 得到了其配位状态方面信息。     

色满-4-酮并[2,3-b]喹啉酮衍生物的合成

以丙酮和适当的芳香醛以及丙二酸二乙酯为原料，合成出未见报道的5-芳基- 1，3-环已二酮作为合成块。利用Friedlaender合成法与2-氨基-3-甲酰基色满-4- 酮缩合，首次完成色满-4-酮并[2,3-b]喹啉酮新四环系化合物的合成。所合成的化 合物均经~1H NMR,~(13)C NMR，IR光谱和元素分析予以证实。化合物2a的结构也从 色谱-质谱联机分析的质谱数据得到进一步确认。化合物的药理学离体实验表明， 化合物2a具有较强的抑制肿瘤细胞生长的活性。     

三苯基锡4－吡啶甲酸酯的合成、性质和晶体结构

用三苯基氯化锡与4-吡啶甲酸钠反应，合成了三苯基锡4-吡啶甲酸酯，并进行 了红外光谱、核磁共振氢谱及质谱表征。X射线单晶衍射表明，化合物属单斜晶系 ，空间群P21，晶胞参数：a=1.6629（3）nm，b=104987(4)nm，c=2.4318(7)nm，β =90.040（5）°，Z=8,Dc=1.1529g/cm^3，R1=0.0543，wR2=0.1086。化合物的晶体 是由两个结构相似但键长和键角不同的独立分子所组成，且每个分子含有两种化学 环境不同的锡原子。它们通过4-吡啶甲酸配体的氮原子桥联，形成五配位三角双锥 构型的一维无限链聚合物。     

Synthesis,crystal structure and properties of a quaternary oxide with a new structure type,BiGaTi4O11

A new quaternary oxide, BiGaTi₄O₁₁ (bismuth gallium tetratitanium undecaoxide), was prepared by heating a mixture of the binary oxides at 1373 K in air. BiGaTi₄O₁₁ melts at 1487 K and prismatic single crystals were obtained from a sample melted at 1523 K and solidified by furnace cooling. The structure of BiGaTi₄O₁₁ was analyzed using single‐crystal X‐ray diffraction to be of a new type that crystallized in the space group Cmcm. A Bi³⁺ site is coordinated by nine O^2? anions, and three oxygen‐coordinated octahedral sites are statistically occupied by Ga³⁺ and Ti⁴⁺ cations. A relative dielectric constant of 46 with a temperature coefficient of 57 ppm K^?1 in the temperature range 297–448 K was measured for a polycrystalline ceramic sample at 150 Hz–1 MHz with a dielectric loss tan δ of less than 0.01. Electrical resistivities measured at 1073 K by alternating‐current impedance spectroscopic and direct‐current methods were 1.16 × 10^?4 and 1.14 × 10^?4 S cm^?1, respectively, which indicates that electrons and/or holes were conduction carriers at high temperature. The optical band gap estimated by the results of diffuse reflectance analysis was 2.9–3.0 eV, while the band gap obtained from the activation energy for electrical conduction was 3.5 eV.     

一种具有Keggin结构的固体杂多酸的合成及其晶体结构

以钨酸钠、氯化钴、醋酸钴及1,3-丙二胺为原料,利用水热合成法制备了一种具有Keggin结构的杂多酸H6[CoW12O40].2.5H2O;利用单晶X射线衍射分析了产物的晶体结构.结果表明,产物中的过渡金属Co2+离子作为中心原子与4个氧原子形成CoO4四面体;CoO4四面体被4个W3O13金属簇包围,与每个W3O13金属簇之间通过共顶点连接而形成[CoW12O40]6-阴离子;六个氢离子作为抗衡阳离子,最终形成固体杂多酸分子.     

1－苯基－3－甲基－4－（6－氢－4－氨基－5－硫杂－2，3－吡嗪）－吡唑啉酮光致变色超分子化合物的合成、结构与性能

通过1－苯基－3－甲基－4－氯乙酰基－吡唑啉酮－5（PMCP）和氨基硫脲（ TSC）缩合，形成了一种含NNS六元杂环的光致变色化合物（PMCP－TSC）。利用元 素分析，MS，”1H NMR，IR和UV光谱进行了表征。通过紫外可见光谱对它的光致 变色性质进行了研究，测出了光致变色反应的动力学常数。并用X线单晶衍射仪测 定了PMCP－TSC变色后的晶体结构，该晶体属单斜晶系，具有P2_1/c空间群，a = 0.105 10(2) nm, b = 0.150 61(3) nm, c = 0.993 70(10) nm, β = 107.890 (10)°, V = 1.496 9(4) nm~3, Z - 4, D_c = 1.417 Mg/m~3, μ = 0.232 mm~(- 1), F(000) = 672, R = 0.033 4, wR = 0.089 6。结构分析表明：其光致变色现 象是由于它在溶剂与光的共同作用下发生了从醇式到酮式的异构化。同时该化合物 经分子间氢键形成二聚体，又通过甲醇与本体分子之间的氢键使化合物形成具有三 维网络结构的超分子化合物。     

N-2-亚甲基-呋喃-二茂铁芳胺衍生物的合成与晶体结构及电化学性质

以邻、间、对-二茂铁苯胺为原料,合成了新的含呋喃二茂铁苯基席夫碱衍生物,还原得到N-2-亚甲基-呋喃-二茂铁芳胺衍生物,通过元素分析,IR,1H NMR和X-射线单晶衍射等分析手段,确证了标题化合物的组成和结构,化合物2 c单晶结构解析表明,2 c属于单斜晶系,P2/n空间群;其HOMO轨道主要由Fe原子及茂环上C的原子轨道组成,LUMO主要由O、N和苯环上C原子构成;电化学实验证明:邻、间、对化合物的电化学性质相似,苯环上取代基位置的不同,对化合物在电极表面的扩散系数影响不大,但对反应速率常数有较大的影响.     

Synthesis,crystal structure,DNA/bovine serum albumin binding and antitumor activity of two transition metal complexes with 4‐acylpyrazolone derivative

Two new complexes, namely [Cu₆L₆] ( 1 ) and [Zn(HL)₂] ( 2 ) (H₂L = N‐(1‐phenyl‐3‐methyl‐4‐propenylidene‐5‐pyrazolone)‐2‐furancarboxylic acid hydrazide), have been synthesized and characterized. Single crystal X‐ray analysis indicates that complex 1 has a hexanuclear structure and complex 2 exhibits a mononuclear structure. The DNA/bovine serum albumin (BSA) binding properties of complexes 1 and 2 were investigated by absorption spectroscopy and fluorescence quenching. Both complexes could effectively intercalate to DNA with calculated quenching constants of 2.6 × 10⁵ and 1.25 × 10⁵ M^?1, respectively. The quenching mechanism of the intrinsic fluorescence of BSA by the complexes was found to be a static one. The cytotoxicities of 1 and 2 were investigated in two human tumor cell lines, human esophageal cancer cells (Eca‐109) and cervical cancer cells (HeLa). Complex 1 exhibits higher antitumor activity than 2 . Furthermore, 1 can inhibit HeLa cells by inducing apoptosis and G0/G1 phase cell cycle arrest. All results demonstrate that 1 and 2 both have DNA/BSA binding capacity and antitumor activity.     

Synthesis and the crystal and electronic structure of Hg4AsI5

New mercury arsenide iodide Hg₄AsI₅ was synthesized and its crystal and electronic structure was determined. The crystal structure is layered. The layers are composed of alternating AsHg₄ tetrahedra and IHg₈ Archimedean antiprisms and are bound by the iodine atoms, which form short Hg-I bonds with all mercury atoms. Band structure calculations provided evidence for very weak interactions between the iodine atoms of the adjacent layers and the ionic character of the iodine atom centering the Archimedean antiprism. Hence, individual [AsHg₄I₄]⁺ clusters and I⁻ anions can be distinguished. Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 5, pp. 736–739, May, 2006. Additional details of the crystal structure study (deposition number CSD-416238) can be obtained from the Fachinformationszentrum Karlsruhe, D-76344 Eggenstein-Leopoldshafen, Germany, fax: +(49)7247-808-666; e-mail: crysdata@fiz-karlsruhe.de.     

Synthesis and Crystal Structure of 5-Methyl- 2-phenyl-4-[（2-p-bromophenylamino）-furylmethylene]-3（2H）-one

A novel 4-heterocyclic acylpyrazolone-based Schiff base compound 5-methyl- 2-phenyl-4-[（2-p-bromophenylamino）-furylmethylene]-3（2H）-one （C21H16N3O2Br） has been synthesized by the reaction of 1-phenyl-3-methyl-4-（α-furoyl）-pyrazolone-5 （HPMαFP） and p-bromoaniline. Elemental analysis, IR spectra and X-ray single-crystal diffraction were carded out to determine the composition and crystal structure of the compound. Crystal data： triclinic system, space group P1^-, a = 9.0936（3）, b = 9.8067（4）, c = 11.6863（4） A, α = 102.512（10）, β = 90.9630（10）, γ = 114.327（10）°, Mr= 422.28, Z= 2, F（000） = 428.0, V= 920.46（11）A^3, Dc = 1.524 g/cm^3,μ = 2.254mm^-1, R = 0.0476 and wR = 0.1318 for 9389 independent reflections （Rint = 0.0122） and 3281 observed reflections （I 〉 2σ（I））. Structural analysis indicates that the compound exists in an amine-one form.     

Synthesis, crystal structure and thermal decomposition of a novel praseodymium supermolecular complex

A novel complex, [Pr(5-nip)(phen)(NO3)(DMF)] (5-nip: 5-nitroisophthalic acid; phen: 1,10-phenanthroline, DMF: N,N-dimethylformamide), was prepared and characterized by single crystal X-ray diffraction, elemental analysis, IR spectrum and DTG-DSC techniques. The results show that the crystal is monoclinic, space group P2(1)/n with a=11.0876(6) Å, b=12.8739(7) Å, c=16.9994(8) Å; β=91.193(4)°, Z=4, D _c=1.822 Mg m^–3, F(000)=1320. Each Pr(III) ion is nine-coordinated by one chelating bidentate and two monodentate bridging carboxylate groups, one chelating bidentate nitryl group, one DMF molecule and one 1,10-phenanthroline molecule. The complex is constructed with one-dimensional ribbons featuring dinuclear units and the one-dimensional ribbons are further assembled into two-dimensional networks by strong π–π stacking interactions. The complex has high stability up to 500°C. The enthalpy change of formation of the compound in DMF was measured using an RD496-III type microcalorimeter with the value of –9.214±0.173 kJ mol^–1.     

Synthesis and crystal structure of a novel luminescent cadmium complex

A novel cadmium complex Cd(IPA)₂(phen)₂ (IPAH?=?isophthanic acid, phen?=?1,10-phenanthroline) was synthesized by hydrothermal methods and characterized structurally by X-ray diffraction. The complex possesses a monomeric molecular structure. Cd(IPA)₂(phen)₂ is orthorhombic, space group Aba2, with a?=?14.670(7), b?=?22.876(8), c?=?9.473(6)?Å, V?=?3179(3)?ų, D _c?=?1.573?Mg?m^?3, Z?=?4, F(000)?=?1520, GOF?=?1.027, R1?=?0.0299, wR2?=?0.0617. Photophysical properties (fluorescence excitation and emission spectra) are reported.